Abstract
Histological grading, that is, grading based only on histological parameters, evaluates the degree of malignancy and the probability of distant metastasis for cancer. Several grading systems have been reported for sarcomas but the two most widely-used systems are the National Cancer Institute and the French systems. Histological grade is recognized as the most important prognostic factor for soft tissue sarcomas. However, this approach presents several limitations such as moderate reproducibility, existence of an intermediate grade and the current nearly universal use of core needle biopsies. A molecular grading system which significantly outperforms histological grading has been recently described for sarcomas. It is based on the expression profile of 67 genes related to chromosome complexity and mitosis management (CINSARC for Complexity INdex in SARComas). In this article we discuss both approaches as well as the future of grading, regarding the respective values of histological and molecular grading systems, validation, extension, refinement and practical use of the molecular grading.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
